Cargando…

Effects of insulin therapy optimization with sensor augmented pumps on glycemic control and body composition in people with cystic fibrosis-related diabetes

OBJECTIVE: Cystic fibrosis (CF)-related diabetes (CFRD) resulting from partial-to-complete insulin deficiency occurs in 40-50% of adults with CF. In people with CFRD, poor glycemic control leads to a catabolic state that may aggravate CF-induced nutritional impairment and loss of muscle mass. Sensor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grancini, V., Alicandro, G., Porcaro, L. L., Zazzeron, L., Gramegna, A., Morlacchi, L. C., Rossetti, V., Gaglio, A., Resi, V., Daccò, V., Blasi, F., Orsi, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501717/ https://www.ncbi.nlm.nih.gov/pubmed/37720540 http://dx.doi.org/10.3389/fendo.2023.1228153

Ejemplares similares

Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Alicandro, G., et al.
Publicado: (2023)

Glucose Control in Post-hemolytic-Uremic Syndrome Diabetes: A New Approach Offered by Sensor-Augmented Pump Therapy
por: Grancini, Valeria, et al.
Publicado: (2022)

SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy
por: Alicandro, Gianfranco, et al.
Publicado: (2022)

Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over
por: Alicandro, Gianfranco, et al.
Publicado: (2022)

P134 SARS-CoV-2 infection in cystic fibrosis during the first pandemic wave in Italy: a multi-centre prospective study with a control group
por: Colombo, C., et al.
Publicado: (2021)

532 Humoral and cell-mediated responses to BNT162b2 mRNA vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Daccò, V., et al.
Publicado: (2022)

ePS4.06 Antibody response to administration of 2 doses of the BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Alicandro, G., et al.
Publicado: (2022)

Telemonitoring: An opportunity in cystic fibrosis lung transplant recipients
por: Corinna Morlacchi, Letizia, et al.
Publicado: (2023)

Breastfeeding in Cystic Fibrosis: A Systematic Review on Prevalence and Potential Benefits
por: Colombo, Carla, et al.
Publicado: (2021)

Impact of COVID-19 on Lung Disease in People with Cystic Fibrosis: A 6-Month Follow-Up Study on Respiratory Outcomes
por: Medino, Paola, et al.
Publicado: (2022)

Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2023)

534 COVID-19 in people with cystic fibrosis and the general population: Severity and virus-host cell interactions
por: Colombo, C., et al.
Publicado: (2022)

P054 Severity of COVID-19 infection in cystic fibrosis patients compared to the general population
por: Rosazza, C., et al.
Publicado: (2022)

SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020
por: Colombo, Carla, et al.
Publicado: (2021)

COVID19 in Lung Transplanted Patients: Chronicles from an Italian Epicenter
por: Morlacchi, L., et al.
Publicado: (2022)

Cystic Fibrosis-Related Diabetes
por: Kayani, Kayani, et al.
Publicado: (2018)

ePS4.07 COVID-19 early vaccination campaign in Italian cystic fibrosis (CF) patients: the experience of the Italian Society for the Study of Cystic Fibrosis (SIFC)
por: Lucca, F., et al.
Publicado: (2022)

(692) Safety and Immunogenicity of the AntiCOVID19 Vaccines in a Cohort of Lung Transplant Recipients
por: Morlacchi, L., et al.
Publicado: (2023)

The Potential Causes of Cystic Fibrosis-Related Diabetes
por: Coderre, Lise, et al.
Publicado: (2021)

Telemonitoring: An Opportunity to Improve Multidisciplinary Care in Lung Transplanted Patients
por: Rossetti, V., et al.
Publicado: (2022)

Lumacaftor/ivacaftor in cystic fibrosis: effects on glucose metabolism and insulin secretion
por: Colombo, C., et al.
Publicado: (2021)

A provider survey of cystic fibrosis related diabetes screening and management practices at North American CF centers
por: Hicks, Rebecca, et al.
Publicado: (2023)

Alteration in glucocorticoids secretion and metabolism in patients affected by cystic fibrosis
por: Podgórski, Rafał, et al.
Publicado: (2022)

Changes of androgen and corticosterone metabolites excretion and conversion in cystic fibrosis
por: Podgórski, Rafał, et al.
Publicado: (2023)

Immunogenicity of BNT162b2 mRNA-Based Vaccine against SARS-CoV-2 in People with Cystic Fibrosis According to Disease Characteristics and Maintenance Therapies
por: Alicandro, Gianfranco, et al.
Publicado: (2022)

Trends in Growth and Maturation in Children with Cystic Fibrosis Throughout Nine Decades
por: Mason, Kelly A., et al.
Publicado: (2022)

The Prognosis of ART Is Not Altered in Cystic Fibrosis Women: A Case-Report Study
por: Braham, Inès, et al.
Publicado: (2022)

The Evaluation of Determinants and Impacts of Co-Production in Healthcare: A Research Protocol for OPAT in Cystic Fibrosis
por: Marsilio, Marta, et al.
Publicado: (2021)

When and how ruling out cystic fibrosis in adult patients with bronchiectasis
por: Gramegna, Andrea, et al.
Publicado: (2018)

Once daily aerosolised tobramycin in adult patients with cystic fibrosis in the management of Pseudomonas aeruginosa chronic infection
por: Mantero, Marco, et al.
Publicado: (2017)

From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2020)

Night Blindness in Cystic Fibrosis: The Key Role of Vitamin A in the Digestive System
por: Norsa, Lorenzo, et al.
Publicado: (2019)

Lack of association between leptin concentrations and cystic fibrosis: A meta-analysis and regression
por: Qi, Hong, et al.
Publicado: (2023)

Gut Mechanisms Linking Intestinal Sweet Sensing to Glycemic Control
por: Kreuch, Denise, et al.
Publicado: (2018)

Cystic fibrosis-related diabetes: The patient perspective()
por: Mason, Kelly A., et al.
Publicado: (2021)

Sustained Glycemic Control With Ivacaftor in Cystic Fibrosis–Related Diabetes
por: Christian, Francis, et al.
Publicado: (2019)

Lung Allograft Dysfunction in a COVID-19 Transplanted Patient is Associated with a Peculiar Immunopathological Phenotype
por: Vaira, V., et al.
Publicado: (2021)

A case of testicular atrophy associated with cystic fibrosis
por: Profka, Eriselda, et al.
Publicado: (2020)

Telemedicine in cystic fibrosis
por: Desimone, Marisa E., et al.
Publicado: (2021)

Obesity in cystic fibrosis
por: Kutney, Katherine A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fbmsd7214cki2s2e4e632giibq